Mrs Rahab M Nduati, | |
1000 W Mulberry Street, Independence, KS 67301 | |
(620) 331-8789 | |
(620) 331-0027 |
Full Name | Mrs Rahab M Nduati |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1000 W Mulberry Street, Independence, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558570234 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 1701705 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Rahab M Nduati, 3009 Johnston Road, Parsons, KS 67357 Ph: (620) 423-3395 | Mrs Rahab M Nduati, 1000 W Mulberry Street, Independence, KS 67301 Ph: (620) 331-8789 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that it has achieved the target enrollment of the minimum of 100 evaluable relapsed or refractory peripheral T-cell lymphoma (PTCL) patients in the BELIEF registration trial.
While sharp debate continues among medical professionals as to whether a radical prostatectomy performed with the assistance of a robotic device is more beneficial than the traditional open surgery method, research just published by investigators at The Cancer Institute of New Jersey (CINJ) shows new evidence supporting the safety of the robotic procedure - including what is believed to be one of the lowest complication rates to date. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The market has changed quite a lot. When I first investigated the industry, and launched BetterYou the natural heath industry was the domain of the educated few. People did a lot of research before they walked into a health store; they knew the questions they wanted to ask and expected quite a good deal of information in return.
A new Canadian study shows that a significant drop in breast cancer incidence among post-menopausal women from 2002 to 2004 coincided with a sharp drop in hormone replacement therapy (HRT) use during the same period. This is the first study to show the link between HRT use and breast cancer among Canadian women.
During the SARS-CoV-2 pandemic, social media platforms have played a major role in conveying information from health care leaders and government officials to communities about how to help stop the spread of COVID-19.
› Verified 6 days ago